RemedyRePack Inc. recalls Clindamycin HCl Capsule
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
- Products
-
- Clindamycin HCl Capsule
- Company
- RemedyRePack Inc.
- Where it was sold
-
Within U.S - PA, VA, FL.
States: Florida, Pennsylvania, Virginia
- Units affected
- 23 bottles/30 count- 690 capsules
- About this recall
- Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02